These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15849866)

  • 41. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease.
    Huot P; Johnston TH; Koprich JB; Fox SH; Brotchie JM
    Neuropharmacology; 2012 Oct; 63(5):829-36. PubMed ID: 22722022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.
    Pérez-Rial S; García-Gutiérrez MS; Molina JA; Pérez-Nievas BG; Ledent C; Leiva C; Leza JC; Manzanares J
    Neurobiol Aging; 2011 Apr; 32(4):631-45. PubMed ID: 19419794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of L-dopa on the heterosexual copulatory behavior of male rats.
    Gray GD; Davis HN; Dewsbury DA
    Eur J Pharmacol; 1974 Aug; 27(3):367-70. PubMed ID: 4418743
    [No Abstract]   [Full Text] [Related]  

  • 46. Behavioral effects in rats following intrastriatal microinjection of manganese.
    Inoue N; Tsukada Y; Barbeau A
    Brain Res; 1975 Sep; 95(1):103-24. PubMed ID: 1171715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
    Shoji T; Tadano T; Kisara K
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):371-8. PubMed ID: 908541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Morphological and chemical reorganizations in parietal cortical neurons in conditions of hyperactivity of the dopaminergic system].
    Gershteĭn LM; Tatarintseva IM; Rakhmanova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):91-3. PubMed ID: 21434462
    [No Abstract]   [Full Text] [Related]  

  • 49. [The role of neuromediators and proteins in genetic and functional organization of animal brain].
    Gershteĭn LM
    Ontogenez; 2001; 32(1):35-40. PubMed ID: 11234391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
    Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
    Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral and neurochemical effects induced by chronic L-DOPA administration.
    Molinengo L; Scordo I; Pastorello B; Orsetti M; Ghi P
    Pharmacol Biochem Behav; 1996 Aug; 54(4):779-85. PubMed ID: 8853203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.
    Hitz K; Heekeren K; Obermann C; Huber T; Juckel G; Kawohl W
    Psychopharmacology (Berl); 2012 Jun; 221(3):389-96. PubMed ID: 22119935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Amphetamine-induced hyperfunction of the dopaminergic system and delta sleep-inducing peptide].
    Popova NS; Dovedova EL
    Ross Fiziol Zh Im I M Sechenova; 1998; 84(1-2):24-9. PubMed ID: 9612853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of L-dopa combined with benserazide on hemodynamics and motor activity in hypoxic rats].
    Boismare F; Le Poncin M; Belliard JP; Hacpille L
    C R Seances Soc Biol Fil; 1975; 169(1):203-8. PubMed ID: 126730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo changes in responsiveness of the caudate nucleus to L-dopa infusion as a function of the estrous cycle.
    Dluzen DE; Ramirez VD
    Brain Res; 1990 Dec; 536(1-2):163-8. PubMed ID: 2085745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies.
    Sturchio A; Gastaldi M; Cariddi LP; Biacchi D; Espay AJ; Franciotta D; Versino M; Mauri M
    Parkinsonism Relat Disord; 2021 Jan; 82():7-9. PubMed ID: 33220521
    [No Abstract]   [Full Text] [Related]  

  • 58. [The characteristics of the nigrostriatal brain system in genetic predisposition to catalepsy].
    Il'enkova MA; Sergutina AV; Orlova EI; Popova NK; Gershteĭn LM; Kolpakov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):37-40. PubMed ID: 8160500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural, functional, and biochemical changes in the brain during modeling of dopamine system disturbances in rats.
    Khudoerkov RM; Dovedova EL; Voronkov DN
    Bull Exp Biol Med; 2007 Jul; 144(1):36-8. PubMed ID: 18256746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mechanism of nootropic digam action in hypofunction of brain dopaminergic system].
    Gerstein LM; Dovedova EL; Popova NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):51-6. PubMed ID: 12938655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.